1.	Phase III Randomized Study of Oral Fluorouracil (5-FU) Plus 776C85 Versus Intravenous 5-FU Plus Leucovorin Calcium as First Line Therapy in Patients with Metastatic Colorectal Cancer (Summary Last Modified 05/1999) Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GW-FUMA3008
2.	Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-02300, E-5296, U10CA021115, CDR0000067038, NCT00003873
3.	Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067642, P30CA016087, NYU-9907, NCI-G00-1718, NCT00005050
4.	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067580, NU-V95N4, NCI-G00-1680, NCT00004901
5.	Phase II Study of Oral Ethynyluracil, Fluorouracil, and Leucovorin Calcium in Patients With Advanced Colorectal Carcinoma (Summary Last Modified 03/2000) Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CLB-9683, CALGB-9683
6.	Phase II Study of a Seven Day Regimen of Oral Ethynyluracil (776C85) Plus a Five Day Regimen of Oral Fluorouracil (5-FU) in Patients with Unresectable or Metastatic Colorectal Carcinoma Who Have Had No Prior Systemic Chemotherapy (Summary Last Modified 04/00) Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-954651, NCCTG-95-46-51
7.	Phase II Study of Fluorouracil (5-FU) Plus Ethynyluracil (776C85) in Patients with Metastatic Pancreatic Adenocarcinoma (Summary Last Modified 05/1999) Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-9629, S9629
8.	Phase II Study of Ethynyluracil (776C85) and Fluorouracil (5-FU) in Advanced or Recurrent Squamous Cell Cancer of the Head and Neck (Summary Last Modified 07/1999) Phase: Phase II Type: Treatment Status: Closed Age: 16 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CAN-NCIC-IND105, GW-564/070, IND105
9.	Phase II Study of Oral Fluorouracil Plus Ethynyluracil in Patients With Advanced Colorectal Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: E-4296, E4296
10.	Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 16 and over Sponsor: NCI, Other Protocol IDs: CDR0000067438, F980826006, UAB-9835, UAB-F980826006, NCI-G99-1653, NCT00004195
11.	SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil Phase: Phase II Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000066138, S9635, U10CA032102, SWOG-S9635, NCT00003254
12.	Phase I Study of Fluorouracil Combined With Ethynyluracil and Leucovorin Calcium in Adult Patients With Solid Tumors (Summary Last Modified 03/2001) Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-97-C-0136B, NCI-T97-0025, T97-0025
13.	Phase I Study of Oxaliplatin, Eniluracil, and Fluorouracil in Patients With Metastatic or Unresectable Malignancies (Summary Last Modified 06/2002) Phase: Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI Protocol IDs: WCCC-CO-99909, WCCC-HSC-2000-157, NCI-T99-0106
14.	A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection Phase: Phase I Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment Status: Completed Age: 19 and over Sponsor: Pharmaceutical / Industry Protocol IDs: Adherex Protocol # AHX-03-101, NCT00264446
15.	A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors Phase: Phase I Type: Treatment Status: Temporarily closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: Adherex Protocol # AHX-03-104, NCT00264472
16.	Eniluracil Hand Foot Syndrome Phase: Phase I Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: HS20667, NCT00827580